Sign In
Get Clay Free →

Suggestions

    John Lo

    Senior Vice President - WW Hematology at Bristol-Myers Squibb

    John Lo is a prominent figure in the biopharmaceutical industry, currently serving as the Chief Commercial Officer at Beam Therapeutics, a position he assumed in November 2024 after his tenure at Bristol-Myers Squibb (BMS) as Senior Vice President of Worldwide Hematology from November 2019 to December 2021.13

    Professional Background

    Dr. Lo has over 20 years of experience in commercial strategy and leadership within the biopharmaceutical sector. His career includes significant roles at major companies such as:

    • Bristol-Myers Squibb: As Senior Vice President, he led the global strategy for BMS's hematology portfolio, which included overseeing the launch of five hematology products, including two cell therapies, Breyanzi® and Abecma®. His leadership contributed to managing a portfolio generating approximately $15 billion in sales.12

    • Celgene: He served as Corporate Vice President for Hematology and Oncology, where he was instrumental in expanding the hematology portfolio and leading pivotal studies.2

    • AstraZeneca: Dr. Lo held multiple roles, including Head of Global Marketing and Market Access, where he launched 18 products globally across various oncology franchises, significantly enhancing their market presence.23

    • Novartis: He was involved in leading the U.S. Hematology Franchise, managing a substantial sales team and driving product launches.2

    Education

    Dr. Lo earned his Ph.D. in Biology from the Massachusetts Institute of Technology (MIT) and holds a Bachelor of Science degree in Biochemistry from the University of Illinois Urbana-Champaign.13

    Current Role

    In his current position at Beam Therapeutics, Dr. Lo is responsible for commercial readiness and leading product and portfolio strategy, continuing his commitment to advancing cancer therapies.3

    Overall, John Lo's extensive background in hematology and oncology positions him as a key leader in developing innovative treatments for blood cancers and related conditions.

    Highlights

    Jul 10 · bms.com
    Hematology - Bristol Myers Squibb
    May 25 · biospace.com
    Erasca Strengthens Clinical and Commercial Leadership with Three ...

    Related Questions

    What are John Lo's key achievements at Bristol-Myers Squibb?
    How did John Lo contribute to the launch of Breyanzi and Abecma?
    What was John Lo's role at Celgene?
    How did John Lo's experience at AstraZeneca influence his career?
    What is John Lo's educational background?
    John Lo
    Add to my network

    Location

    New York City Metropolitan Area